A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Clinical trial NCT01533428 · COMPLETED
Trial details
- NCT number
- NCT01533428
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-02-01
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.